Table:
Factors associated with interest in doxycycline for STI post-exposure prophylaxis (doxycycline-PEP) and reported sexually-transmitted infection (STI) in the last year (N=1,301)
| Overall (N=1,301) |
AOR for doxy-PEP interest [95% Confidence Interval (CI)] |
|
|---|---|---|
| Age, median [inter-quartile range (IQR)] | 34 (28–44) | 1.11 (0.97–1.29)1 |
| Race/ethnicity: White | 48% | Ref. |
| African-American | 16% | 1.83 (1.08–3.11) |
| Asian | 6% | 1.09 (0.57–2.09) |
| Latinx | 25% | 1.74 (1.14–2.65) |
| Multiple/other | 7% | 0.90 (0.50–1.62) |
| Group: People Living with HIV | 16% | Ref. |
| HIV-uninfected on PrEP | 37% | 0.86 (0.51–1.46) |
| HIV-uninfected not on PrEP | 47% | 0.89 (0.52–1.50) |
| Anal or vaginal/front-hole sex partners, median (IQR) | 5 (2–15) | 0.98 (0.95–1.01)2 |
| Condomless sex last 6 months | 80% | 1.86 (1.27–2.71) |
| Bacterial STI last year | 39% | 1.64 (1.13–2.39) |
| City: San Francisco | 16% | Ref. |
| Atlanta | 13% | 1.57 (0.82–2.97) |
| Birmingham | 1% | 1.11 (0.30–4.11) |
| Chicago | 16% | 1.20 (0.68–2.10) |
| New York City | 38% | 0.79 (0.51–1.25) |
| Seattle | 10% | 0.88 (0.39–1.63) |
AOR: adjusted odds ratio
1
Scaled per ten years
2
Scaled per 5 partners